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REGULATORY PHYSIOLOGY DISCIPLINE SCIENCE PLAN
1.0 INTRODUCTION
The focus of the Regulatory Physiology discipline of the Space Physiology and
Countermeasures Program is twofold. First, to determine and study how microgravity
and associated factors of space flight affect the regulatory mechanisms by which
humans adapt and achieve homeostasis and thereby regulate their ability to respond
to internal and external signals; and, second, to study selected physiological systems
that have been demonstrated to be influenced by gravity. The Regulatory Physiology
discipline, as defined here, is composed of seven subdisciplines: 1) Circadian
Rhythms, 2) Endocrinology, 3) Fluid and Electrolyte Regulation, 4) Hematology, 5)
Immunology, 6) Metabolism and Nutrition, and 7) Temperature Regulation.
1.1 PURPOSE
The purpose of this Discipline Science Plan is to provide a conceptual strategy for
NASA's Life Sciences Division research and development activities in the area of
regulatory physiology. It covers the research areas critical to NASA's programmatic
requirements for the Extended-Duration Orbiter, Space Station Freedom, and
exploration mission science activities. These science activities include ground-based
and flight; basic, applied, and operational; and animal and human research and
development. This document summarizes the current status of the program, outlines
available knowledge, establishes goals and objectives, identifies science priorities,
and defines critical questions in regulatory physiology. It contains a general plan that
will be used by both NASA Headquarters Program Offices and the field centers to
review and plan basic, applied, and operational intramural and extramural research
and development activities in this area.
2.0 GOALS AND OBJECTIVES
2.1 GOALS
The long-range goals of the NASA Regulatory Physiology research program are to:
• Determine and understand the short- and long-term physiological
adaptation(s) of humans to the space environment
° Evaluate the efficacy of physiological and performance
countermeasures.
2.2 OBJECTIVES
The objectives of the subdisciplines of the NASA Regulatory Physiology research
program are listed below:
Circadian Rhythms: Describe and understand the effects of gravity and
the space-flight environment on biological rhythms of various physiological
systems
• Endocrinology: Understand the hormonal mechanisms that underlie the
physiological responses to space flight
Fluid and Electrolyte Regulation: Describe and understand the effects of
space flight on renal function, fluid distribution, and electrolyte regulation in
humans
Hematology: Characterize the anemia that is present following space
flight and determine the causes and mechanisms involved in the loss of
red blood cell mass
• Immunology: Define and understand the changes in immunocompetency
that occur in response to space flight
Metabolism and Nutrition: Understand and describe changes in
metabolism that occur in space flight and define how and to what
extent nutritional requirements may be altered
° Temperature Regulation: Understand the effects of gravity and space
flight on the regulation of body temperature and thermal comfort of the crew.
This plan incorporates recommendations from reports by the Committee on Space
Biology and Medicine (Goldberg), the NASA Life Sciences Strategic Planning Study
Committee (Robbins), and the Federation of American Societies for Experimental
Biology (FASEB) (see 12.0, Selected References).
Current knowledge about physiological changes associated with short-term and long
term space flight is summarized in Appendix 1, which is from Space PhysiolQgy and
Medicine, 2nd. edition, by Drs. Nicogissian, Leach-Huntoon, and Pool.
3.0 CIRCADIAN RHYTHMS
3.1 INTRODUCTION
Circadian rhythms (i.e. characteristics of living systems that cycle with a relatively fixed
and predictable period of about 24 hours) are a fundamental property of all eukaryotic
organisms. Indeed, circadian rhythmic variations are observed in almost all
biochemical, cellular, physiological, and behavioral systems.
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It has been clearly established that these rhythms are generated by "internal (i.e.
endogenous) biological clocks." The circadian clock is normally entrained or
synchronized to the 24-hour changes in the physical environment by external signals,
such as the light-dark cycle. Extensive biochemical, molecular and cellular studies are
ongoing to elucidate the biological mechanisms by which circadian rhythms are
generated and entrained. Biological rhythms are a common feature of most, if not all,
regulatory systems, and the proper timing of circadian rhythms is vital for the optimal
health of the organism. Recent studies in humans have focused on the importance of
circadian rhythms and sleep for normal mental and physical health, and how these
functions can be influenced to optimize human performance. These studies
emphasize the need for the proper scheduling of work-rest-sleep activities and design
of lighting environments for ensuring optimal human performance.
A number of reports, from both within and outside of NASA, have emphasized the need
to examine circadian rhythms in the space environment because the study of biological
rhythms in space is important for the health and performance of space crews.
3.2 BACKGROUND AND CURRENT KNOWLEDGE
The fundamental question regarding circadian rhythms that was the focus of early
NASA-sponsored research was, "Do circadian rhythms persist in the absence of
environmental time cues (e.g. light or temperature changes) in outer space?" The
answer to this question was important for addressing the issue of whether or not the
clock that regulates 24-hour rhythms resides within the organism or within the Earth's
physical environment. The answer was clear: circadian rhythms persist outside of the
Earth's environment, and thus the clock(s) regulating circadian rhythms are within
living organisms. Studies carried out on Spacelab in the fungus Neurospora crassa
and in the unicellular green alga E;hle,m_vdomonas reinhardi, have clearly
demonstrated that circadian rhythms persist in space. Of great importance, however,
is the finding that rhythms can show abnormal amplitudes and phase relationships to
the light-dark cycle in space. Such abnormalities in biological rhythms have been
observed in plants, rats, and monkeys studied on various U.S. and Soviet space
missions. In addition, ground-based studies with animals have shown that exposure
to hypergravity can also have disruptive effects on various circadian rhythms in
mammals.
Few attempts have been made to study human circadian rhythms in space in any
detailed fashion. While physiological data were recorded during isolated nights of
sleep on three of the Skylab missions, rhythms in the sleep-wake cycle have not been
monitored in space. In general, reasonably good sleep has been reported in space,
although a number of abnormalities that relate to specific stages of sleep have been
noted. Essentially, nothing is known about how other circadian rhythms are affected
by the space environment. Of particular concem is how circadian patterns of various
hormones and/or metabolic processes may be altered in reduced gravity.
3.3 CRITICAL QUESTIONS (In priority order)
. What are the effects of the space environment on sleep, sleep cycles, or
the generation, expression (period, phase, amplitude and/or waveform),
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and entrainment of metabolic, endocrine, and/or behavioral circadian
rhythms? Of these effects, which result from altered gravity and which
result from other environmental factors?
What are the effects of intermittent and variable gravity fields on circadian
rhythms, and how does this affect the use of artificial gravity as a
countermeasure to microgravity? Can gravity be used as a potential
synchronizing agent of circadian rhythms? What are the physiological
mechanisms that mediate the effects of gravity on the biological clock?
What are the optimal environmental conditions for ensuring
synchronization of circadian rhythms in space, and what are the most
appropriate work-rest schedules for ensuring optimal health and
performance?
What are the effects of space-induced alterations in circadian rhythms on
human health and performance? What are the times for peak
performance dur-k_-E-_A-?.
What are the optimal conditions for synchronizing the circadian rhythms
of mission control personnel to the mission schedules? How is
performance of mission personnel affected by their various work-rest
schedules?
What are the effects of exercise on circadian rhythms and sleep? What
pharmacological and nonpharmacological (e.g. light, exercise) agents
can be used to reset the human biological clock? What are the effects of
routine administration of pharmacological agents in space on circadian
rhythms and sleep?
What are the appropriate ground-based analogs for studying the effects
of extreme environments on human circadian rhythms?
What are appropriate mathematical and computer models for simulating
the effects of the space environment on circadian rhythms?
What are the effects of non-gravity-related physical-chemical and
psychological space-flight-induced stressors on circadian rhythms and
sleep?
What are the long-term effects of the space environment on the
interaction between the circadian and reproductive systems?
What roles do age and gender play in the response of the circadian
system to the space environment?
What are the effects of cephalad fluid shifts on circadian rhythms?
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4.0 ENDOCRINOLOGY
4.1 INTRODUCTION
The transmission of all information in the body from one cell system to a more distant
target depends almost entirely on neurohumoral, neuroendocrine, and endocrine
communication systems. In recent years, endocrinology has changed from the study
of a relatively few, cimumscribed regulatory systems and metabolic effects to include
more diffuse and extensive control mechanisms within and outside (e.g. kidney, gut)
the central nervous system m often with widespread regulatory effects.
Hormones play an extensive modulatory role throughout the body. Endocrine and
neuroendocrine secretions are the basis by which regulatory changes are developed
and sustained. Knowledge of changing synthesis, release, and response during
space flight is essential to our understanding of how the body adapts to this new
environment. Of particular importance is the effect of hormones on the brain m not
only in terms of homeostatic regulation of such parameters as body temperature, fluid
balance, or biological rhythms -- but also of behavior, emotional state, and
performance. It, therefore, is central to the understanding of the role of gravity in the
evolution and regulation of living systems, as well as of the induced physiological and
behavioral changes that occur in humans in space, to understand the endocrine and
metabolic processes involved in adapting to that environment.
The need to measure and investigate changes in endocrine regulatory systems was
recognized from the start of the manned space program. At first, the primary interest
was related to the ability of crews to withstand and respond to the stresses of space
flight. Data from in-flight studies continually demonstrate that endocrine mechanisms
underlie many of the major biomedical changes during space flight.
Recommendations by review and advisory committees have consistently emphasized
the need to support experimentation to determine the endocrine mechanisms
underlying the fluid, electrolyte, cardiovascular, musculoskeletal, immune,
erythropoietic, and general metabolic responses to space flight.
Over the course of the manned space flight programs since 1965, a wide variety of
endocrine hormone and related measurements have been made. In-flight
measurements on Gemini VII, Skylab, and the more recent Shuttle flights have
revealed clear and consistent patterns of change in many systems. Additionally,
recent data from rat tissue obtained after COSMOS and Spacelab missions have
suggested possible molecular mechanisms that might explain endocrine irregularities.
These studies have contributed to the development of several effective
countermeasures. Negative feedback effectiveness on CNS regulatory mechanisms
may be reduced. Age and gender, as well as sleep, emotions, extravehicular activity
(EVA), and the physical activity induced by workload should be considered along with
prescribed medications and countermeasures in attempts to evaluate the effects of
microgravity on endocrine systems. Implementation is also an important factor. For
example, COSMOS data suggest that growth hormone concentrations (as assayed by
radioimmunoassay) do not reflect biological activity. This may also be the case for
ACTH and insulin.
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4.2 BACKGROUND AND CURRENT KNOWLEDGE
Description of the response of the human endocrine system to space flight has come
from comprehensive measurement of hormones in the blood and urine of crews before
and after flight as well as during flight (Gemini, Apollo, Skylab, and STS). Data from
animal flight experiments (SL-3, SLS-1, COSMOS) reflect pre- and postflight
measurements only. Nevertheless, a broad spectrum of endocrine system responses
to space flight have been measured in rats, including growth hormone and
reproductive, calcium regulating, thyroid, and adrenocortical hormone changes.
Considerable evidence has accumulated to indicate that head-down bedrest provides
an acceptable ground-based simulation of the effects of prolonged weightlessness.
Nevertheless, there are differences in some of these effects and in the time course of
the measured changes. Bedrest cannot provide zero gravity, though the effects of
gravity in the Gz vector are greatly diminished. Furthermore, the motivation cannot
begin to compare with actual flight. Space flight, on the other hand, does not merely
provide weightlessness, but is a composite of operational conditions so that in addition
to weightlessness, contributions to the overall results are made by the emotional and
physical forces of liftoff; the debilitating symptoms of space sickness; and the isolation,
workload, sleep and rhythm disturbances, and interactions with life support systems
and medications. These differences must be considered in extrapolating endocrine
data from ground-based studies to spaceflight and emphasize the need for in-flight
confirmation of findings from ground-based studies. On the other hand, more in-depth
investigation, particularly of mechanisms and of the value of countermeasures, can be
done more simply, practically, accurately, and economically with bedrest studies.
Weightlessness and bedrest alike produce a characteristic headward redistribution of
blood volume. This shift results in increased intrathoracic pressure, stimulation of
cardiopulmonary receptors, and stimulation of aortic and carotid baroreceptors. Such
stimulation results in an inhibition of the sympathetic nervous system (SNS), of the
renin-angiotensin-aldosterone system, and of antidiuretic hormone (ADH, or arqinine
vasopressin, AVP). Diuresis and natriuresis and the resultant decrease in blood
volume constitute the homeostatic response to such postural change.
Several studies have now documented a significant increase in the plasma
norepinephrine (NE), plasma renin activity (PRA) and AVP in response to standing,
upright tilt, or other orthostatic stress after bedrest (and presumably on return to Earth's
l-g). Individuals who do not show decreased orthostatic tolerance after bedrest show
an increased NE, PRA, and AVP response m in contrast to those who do show
orthostatic intolerance, where NE, PRA, and AVP response are not increased after
bedrest. The endocrine system clearly underlies the ability to response to orthostatic
stress, not only by regulating blood volume but also by direct action on vascular
smooth muscle and the kidney.
In addition, the hypothalamo-pituitary-adrenocortical responsiveness to orthostatic
stress is similarly affected by bedrest and space flight. This system was among the first
measured before and after the Mercury flights, which lasted from only 15 minutes to
some hours. Throughout the various missions, data have indicated that space flight is
indeed stressful, although weightlessness may in fact be a less stressful condition than
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Earth's 1-g. For instance, although the cortisol rhythm remains reasonably stable, its
amplitude and daily mean are lower indicating a lower total daily output. On the other
hand, it is difficult to draw absolute conclusions since both flight and ground-based
simulation (bedrest) measurements indicate that in the process of adapting to and
attaining a new equilibrium in the absence of gravity, or with changes in the directional
forces of gravity, the hypothalamo-pituitary-adrenal system appears to become
unstable and decoupled. Evidence so far, however, has been indirect because classic
tests of function have not been performed in either condition. Such a complete
evaluation should be carried out, because this system is essential for the normal
function and homeostasis of many essential body functions including reproduction,
immunity, metabolism, and response to stress. The pituitary-adrenal system has also
been shown to affect behavior and performance, often in different ways. In particular,
more recent clinical work has emphasized the importance of the actions of CRF on the
brain, not only in regulating the stress response but also in regulating mood and
behavior, including food consumption and thirst. Similarly, thyroid stimulating
hormone, like CRF has been found to have beneficial effects in seasonal,
environmental depression.
Little unusual information has been obtained from flight or ground-based
investigations regarding reproductive function. In short Shuttle missions, as in 7-day
bedrest studies, female reproductive hormones and their cycles do not appear to be
greatly affected. The effect of more prolonged exposures is completely unknown. On
the other hand, animal data show decreases in testosterone after flight, but the
significance of this is unclear. However, for prolonged missions, reproductive
regulation and function should be addressed.
Finally, the interaction of endocrine regulatory system changes that occur as adaptive
responses to microgravity must be considered in addressing how this altered
regulatory baseline function may influence the response of other endocrine, non-
endocrine, and behavioral and performance functions. Although we now believe that
many of the known endocrine responses to space flight are adaptive responses to
acute changes in hydrostatic pressures, there is no way of predicting from the data of
the short missions achieved so far, what effect removal from the influence of millions of
years of gravity would have during extended stays in microgravity.
4.3 CRITICAL QUESTIONS (In priority order)
. What are the effects of space-induced endocrine changes on the function
of other homeostatic systems (e.g. cardiovascular, central nervous
system, immune function, thermoregulation, musculoskeletal system,
gastrointestinal system, and energy metabolism)?
. What are the hypothalamic-pituitary-adrenal and opioid system
responses to normal space-flight events (e.g. EVA, countermeasures) as
well as to reference "standardized" physical, emotional, and
environmental stimuli?
. What are the acute and chronic effects of space flight on endocrine
system homeostasis and responsiveness?
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How does space flight affect the pharmacodynamics of hormone action,
the permeability of the blood-brain barrier, and the action and
metabolism of hormones?
How do altered biological rhythms associated with long-term space flight
affect hormone secretion and function and vice versa?
How does prolonged or repeated space flight affect regulation of
mammalian reproductive cycles and behavior (including species, sex,
and age differences)?
5.0 FLUID AND ELECTROLYTE REGULATION
5.1 INTRODUCTION
Regulation of body fluid and electrolyte balance is a fundamental homeostatic function
of the body. Severe dehydration can be accompanied by circulatory collapse. Losses
of electrolytes, especially sodium and potassium, can alter cardiac performance,
thermal regulation, plasma osmolality, and cellular electrochemical gradients. To
prevent these conditions from occurring, the body has developed feedback
mechanisms that control both its fluid and electrolyte composition. Although the two
functions are interdependent and share certain controls, some of the mechanisms
controlling each are independent of the other. It should be noted that physiologists
have, in general, concentrated their efforts on understanding the mechanisms
controlling fluid and electrolyte losses. Much less effort has been spent in
understanding the mechanisms controlling intakes of fluid and electrolytes.
The regulation of fluid and electrolyte balance is a fundamental homeostatic function
of the body. It is important to understand as completely as possible the changes that
occur during exposure to microgravity, as well as the changes that occur in the
hormones and other factors regulating these balances. A more complete analysis of
renal function is required to support the longer missions that will be involved with
Space Station Freedom and beyond. Whether the changes in blood urea nitrogen
that have been reported indicate changes in renal function should be investigated.
The mechanisms leading to the acute loss of fluid and electrolytes during the initial
phase of adaptation to microgravity are not fully understood. Neither do scientists
understand the mechanisms operative in the regulation and maintenance of fluid and
electrolyte balance during the chronic phases of microgravity exposure. The
magnitude, time course, and steady-state level of changes in key electrolytes and
different body fluid compartments must be studied throughout the process of
adaptation to microgravity. The functional relationship between changes in fluid and
electrolyte regulatory mechanisms and cardiovascular system function and
deconditioning during microgravity must be studied. Space Station Freedom will offer
the opportunity to validate antiorthostatic bedrest as a method of simulating
microgravity for studying long-duration space-flight-induced alterations in fluid and
electrolyte metabolism.
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5.2 BACKGROUND AND CURRENT KNOWLEDGE
It has been clear from the earliest manned space flights that exposure to microgravity
is accompanied by a shift of fluids from the more peripheral (legs and feet) to the more
cephalad part of the body. Puffiness of the face, reduction in the volume of the lower
limbs, and other changes characteristic of this shift of fluid have been reported during
exposure to microgravity. Similar changes in fluid distribution occur with horizontal
and head-down bedrest.
The shift of fluid induces a net reduction in body fluids that contributes to a loss in body
weight. The latter appears to be sustained throughout the period of exposure to
microgravity and has been reported for virtually all space flights. The mechanisms
responsible are not completely understood and may involve changes in the rate of
secretion of a number of hormones, including aldosterone, catecholamines, atrial
natriuretic hormone, antidiuretic hormone, and others. In addition, changes in renal
hemodynamics (renal plasma flow) and glomerular filtration rate may contribute.
Toward the end of some U.S. and Soviet missions, fluids with salt have been
prescribed to increase extracellular volume for the purpose of restoring orthostatic
competence in preparation for return to 1 g. Except for partial repletion of water and
salt shortly before re-entry, means of intervention to prevent fluid and electrolyte loss
during the mission have not been identified. Furthermore, it is not clear whether such
intervention is needed during the mission, since these changes may, in fact, be
adaptive. If so, attempts to alter them could be counterproductive.
Decreases in the concentrations of sodium and potassium in serum, accompanied by
an increase in the concentration of chloride, were reported after STS 1-4. Similarly,
decreases in the concentration of sodium in serum were reported for the Apollo 8, 9,
and 10 missions, while increases were observed for the Apollo 7 and 11 missions.
Decreases in the concentration of potassium in serum were reported for the Apollo 7
and 8 missions, with an increase in the concentration of chloride in the Apollo 7
mission and a decrease in the Apollo 8 and 10 missions. An average decrease of 6.7
percent in exchangeable potassium occurred in astronauts of the Skylab 2, 3, and 4
missions. A decrease in the concentration of aldosterone in plasma was also reported
after the STS 1-4 missions. In the latter missions, verification of the loss of sodium and
potassium during exposure to microgravity was seen after return to 1 g, when retention
of these electrolytes occurred in conjunction with an increase in the concentration of
aldosterone in plasma.
Biomedical investigations associated with Skylabs 2, 3, and 4 identified a reduction in
total body water from 1.1 to 4.5 percent during exposure to microgravity. An average
reduction in extracellular fluid volume of about 2 percent occurred in the astronauts of
these three missions. Plasma volume, measured before and after Gemini flights, was
reduced by 13 percent after the 4-day flight, by 6 percent after the 8-day flight, and by
10 percent after the 14-day flight.
A brief review of the changes occurring in fluid and electrolytes during exposure to
microgravity was published by the Life Sciences Research Office of the Federation of
American Societies for Experimental Biology in 1986. The major thrust of the review,
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however, was in the area of nutrition. Several additional publications (see 6.0,
Selected References) have also reviewed this area in greater depth.
Little direct information is available with respect to changes in renal function that may
occur during exposure to microgravity. The early study of Lutwak and co-workers,
carried out on the astronauts of Gemini VII, assumed that no changes occurred.
Although no measures of renal clearance of any substances were made, increases in
blood urea nitrogen (BUN) immediately after flight of 25 percent above preflight values
in astronauts of STS 1-4 were reported. A similar increase was observed in
astronauts from the Apollo 10 mission.
Thus, a question arises as to whether renal function may be impaired by exposure to
microgravity. It has been postulated, based on the results of the Apollo missions, that
a decrease in renal blood flow may have occurred. The nine crewmen in the Skylab
program were in negative fluid balance during the first 6 days of flight. Reduced intake
and an increase in insensible water loss (because of the low ambient humidity) are
probably factors in the negative fluid balance. The possibility of potential changes in
the mechanisms inducing thirst and drinking during exposure to microgravity has not
been considered to date.
5.3 CRITICAL QUESTIONS (In priority order)
o What are the time course and magnitude of fluid shifts and changes in
fluid compartment volumes during acclimatization to hypogravity and
during return to 1 g after flight?
o What are the fluid and electrolyte regulating mechanisms underlying the
cardiovascular responses to microgravity?
o What are the mechanisms for the chronic adaptive shifts in fluid and
electrolytes during space flight? How does the new steady state affect
the body's ability to respond to heat stress, electrolyte loading, EVA, and
countermeasures?
1 What are the effects of microgravity on renal function, e.g. stone risk and
blood urea nitrogen? Are the effects progressive? Are they reversible?
Are there differences in filtration, reabsorption, secretion, and excretion?
1 What are the best methods to accurately measure fluid loss, fluid intake,
plasma volume, extracellular fluid, total body water, and interstitial
volume in space flight?
6. What are the time course and magnitude of the diuresis, natriuresis, and
kaliuresis resulting from exposure to hypogravity?
1 What are the mechanisms inducing the acute loss of fluid and
electrolytes in microgravity?
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What are the effects of circadian rhythm changes in space flight on the
responsiveness of the fluid and electrolyte system?
What are the mechanisms regulating thirst and electrolyte appetite during
space flight?
What are the roles of renal blood supply and renal electrolyte handling
in extracellular fluid volume control during simulated and actual
microgravity?
What are the relationships of fluid and electrolyte responses to space
flight on sensory thresholds and space motion sickness?
What are the effects of pressure and gas composition in space flight and
during EVA on changes on fluid and electrolyte regulation?
To what extent does the qastrointestinal system modify electrolyte and
fluid balance control during space flight?
6.0 HEMATOLOGY
6.1 INTRODUCTION
Decreases in red blood cell mass and plasma volume have been observed
consistently following manned space flights. Losses of red blood cell mass by U.S.
astronauts have ranged from 2 to 21 percent. Based on postflight estimates of total
hemoglobin, Soviet cosmonauts who have engaged in long-duration space missions
have exhibited somewhat greater losses. Restoration of red blood cell mass appears
to require from 4 to 6 weeks following return to Earth, regardless of the duration of
space flight.
There are no reports suggesting that "astronaut anemia" has impaired the health and
performance of members of space crews either during flight or after flight.
Nevertheless, in-flight illnesses, injuries, or life support malfunctions could conceivably
alter cardiovascular-respiratory requirements such that a 10 to 15 percent decrement
in red blood cell mass could compromise crew safety and performance. Moreover,
uncertainties exist as to the probable responses of the hematopoietic system during
possible future space missions lasting a year or longer. Therefore, loss of red blood
cell mass represents a contingent operational medical problem.
From the standpoint of the biologic effects of space flight, red blood cell mass loss is a
significant, predictable response that may be a model of the effects of space flight on
human proliferative tissues. Despite substantial investigation in the United States and
Soviet Union, the etiology, biologic mechanisms, and potential operational
significance of the loss of red blood cell mass has not been adequately defined.
Authorities in space medicine, hematology, and related specialties regard this loss as
one of the endpoints of physiologic adaptation to weightlessness. While the primary
cause appears to be the influence of microgravity itself, the etiology is probably
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multifactorial, including such influences as hypokinesis/hypodynamia, bone
demineralization and remodeling, muscle atrophy, altered hemodynamics, and
nutritional and metabolic disturbances. Other environmental influences such as
hyperoxia, hypobaria, ionizing radiation, toxic contaminants, and accelerative stresses
of space flight are probably not causal factors; however, their possible influence
remains to be established.
Available information does not permit reliable extrapolation of the probable course of
erythrokinetics during future space missions lasting a year or longer, nor can the
possibility that red blood cell mass loss could compromise the safety and effectiveness
of crewmembers be ruled out in flights complicated by illness, injury, or life support
equipment malfunction.
A lack of sufficient information on several essential hematologic parameters
emphasizes the need to expand data on red cell losses.
6.2 BACKGROUND AND CURRENT KNOWLEDGE
Red blood cell mass loss has been referred to as "astronaut anemia," "space anemia,"
or "anemia of space flight." Red blood cell mass losses of 2 to 21 percent are
accompanied by decreases in hemoglobin mass (12-33 percent) and losses of 4-16
percent in plasma volume. Erythrocyte and hemoglobin concentrations in the blood
remain constant, suggesting that losses in mass are related to a complex series of
physiological responses to weightlessness, the most significant of which may be
plasma volume loss. Evidence from prolonged flights by U.S.S.R. cosmonauts shows
losses of hemoglobin mass without in-flight recovery from red blood cell mass losses.
As with the results from U.S. studies of astronauts, postflight recovery is slow, taking up
to 30 days or more.
Hematologic studies were conducted on four crewmembers on Spacelab 1 and six
matched control subjects who served as a ground-based control group. As expected,
hemoglobin concentration and hematocrit of the four Spacelab subjects increased 22
hours after exposure to weightlessness. On landing, hematocrit, red blood cell mass,
plasma volume, and reticulocyte counts were reduced. However, while decreases in
serum erythropoietin were noted in all flight crewmembers, the reductions in
erythropoietin levels were not statistically significant. This lack of a significant
reduction in serum erythropoeitin levels accompanied by a significant decrease in
reticulocyte number, together with the progressive loss of red blood cell mass during
flight, suggests that inhibition of erythropoiesis was not the major or sole cause of red
blood cell mass loss.
While there is no evidence that the reductions in red blood cell mass, in numbers of
circulating reticulocytes, and in plasma volume affect performance adversely, their
confirmed occurrence is viewed as an issue requiring investigation and explanation.
The causes and mechanisms are poorly understood despite considerable
investigation over the past several years. Although evidence is incomplete, most
investigators consider the anemia of space flight to be an endpoint of the processes of
adaptation to weightlessness. That is, it is a physiologic rather than a pathologic
12
response to microgravity and other aspects of space flight, just as polycythemia is a
response to altitude.
While the number of in-flight animal studies has been limited, their results are
significant in terms of factors causally related to red blood cell mass losses. Life-span
of the red blood cells of male pathogen-free Wistar rats flown for 19.5 days in
COSMOS-782 was reduced 5.4 percent and hemolysis of red blood cells was
increased threefold when compared to control animals kept in a vivarium.
In experiments with pathogen-free male Wistar rats flown on Cosmos-936 for 18.5
days, hemolysis of red blood cells was apparently related only to weightlessness
because little or no hemolysis occurred in those rats that were centrifuged inflight to
produce an artificial unit gravitational field.
Because bone marrow can compensate for reduced red blood cell life-span by
increasing production of red blood cells, red blood cell mass might be expected to
remain constant. But red blood cell mass decreased in rats held in the weightless
condition not only because of hemolysis but also, probably, inhibition of erythropoiesis
as illustrated by reduced hematopoietic responsiveness of marrow from space-flown
rats.
6.3 CRITICAL QUESTIONS (In priority order)
. Does the well documented decrease in red blood cell mass termed
"anemia of space flight" represent a normal microgravity-associated
adaptive process (self-limiting) or a transient response (self-correcting)to
changes brought about by various space-flight-related stimuli
(stressors)?
. What are the time courses and magnitudes of changes in the
erythropoietic system during space flight?
. What is the most effective way to restore red cell mass during simulated
and actual microgravity? Should red cell mass be restored during space
flight?
= Are these acute or chronic changes and are they of sufficient magnitude
or duration to pose an unacceptable medical risk and warrant the
development of countermeasures (prophylactic or therapeutic)?
o What is the relationship between altered hematocrit, renal function, and
erythropoietin levels in micro-, partial, and unit gravity?
. What are the major factors and associated mechanisms that contribute to
the "anemia of space flight"?
a° What controls the alterations in red cell production or
survival?
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b. Does the loss of red cell mass result from an impairment of the red
blood cell proliferation process or to differential margination,
reticuloendothelial sequestration, cell death, or other
mechanisms?
Is the "anemia of spaceflight" related to a direct effect of microgravity or
other space-flight-induced stressors on bone marrow structure, function,
or cellular interaction?
Are periods of recovery from "anemia of space flight" physiologically
analogous to those in subjects who donate blood or otherwise undergo
phlebotomy, and can this recovery be accelerated?
7.0 IMMUNOLOGY
7.1 INTRODUCTION
The immune system of higher animals is composed of the cells, tissues, and secretory
products that allow the organism to discriminate "self" from "nonself" and to carry out
the actions necessary to destroy and eliminate nonself entities from the body. Thus,
the body is protected from exogenous (microbial) or endogenous (neoplastic) threats
to survival. Besides the critical functions of monitoring the body's internal milieu for
nonself molecules/organisms, such as bacteria, fungi, and viruses, the immune system
plays an important "immune surveillance" role by identifying neoplastic or otherwise
antigenic, ally transformed cells and destroying them before they can form a tumor
and/or metastasize. This latter function will be particularly important in a relatively high
radiation environment or when crews are otherwise exposed to environmental
toxicants (associated with space flight) that could increase the rate of mutation or
tumorigenesis.
Because of the importance of its surveillance role in host defense, the organs and
tissues of the immune system are widely distributed throughout the body (via blood
and lymph). Both specific and nonspecific immunological functions are exhibited in
higher animals.
Nonspecific immunity is a primary task of phagocytic cells (basophils, neutrophils,
eosinophils, and macrophages) that form the body's first line of cellular defense.
Specific immunity is functionally subdivided into "humoral" and "cell-mediated"
systems. The effector cell in humoral immunity is the B-lymphocyte, which after
encountering a foreign antigen or substance undergoes a series of cellular divisions
(clonal expansion) to become a "plasma cell." The plasma cell produces millions of
antibodies that are specifically targeted to the foreign substance that was initially
encountered. The effector cells of the cell-mediated immune response are primarily
the T-lymphocytes. In recent years, the important functions of a variety of
immunoregulatory molecules (lymphokines, cytokines, enkephalins, etc.) secreted by
accessory immune cells such as monocytes and macrophages, T and B cells
themselves, and cells within the neuroendocrine system have been documented.
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Studies to date, primarily on short-term space flights, suggest that changes in
microbiological flora associated with long-term human habitation of closed
environments include increases in antibiotic resistance; spread of normal skin flora to
other body parts; increased interpersonal transfer of potential pathogens,
"simplification" of species; growth to higher population densities, emergence of
opportunistically pathogenic strains of bacteria and fungi; and loss of general (herd)
immunity to bacterial, fungal, or viral strains present on/in newly arrived crewmembers.
Any or all of these changes could be deleterious to human health, particularly if the
humans were immunocompromised. The potential health risks associated with short-
term flights (listed above) will probably be extended and increased with the advent of
long-duration missions such as colonization of the Moon and Mars or other missions
involving long-term human habitation of closed environments.
As the NASA manned space flight program readies itself for the challenges associated
with maintaining human health and safety on long-duration flights, the question of the
time course, magnitude, and potential clinical significance of changes in immune
competency must be addressed with a program of clinical and scientific investigations
involving carefully designed and integrated ground-based and in-flight studies. Any
potential space-flight-related decrement(s) in immune function that would affect the
identification and elimination of infectious organisms or surveillance of the internal
environment for transformed cells must be identified rapidly, their potential impact on
crew health and safety assessed, and, if required, appropriate prophylactic or
therapeutic measures developed.
7.2 BACKGROUND AND CURRENT KNOWLEDGE
U.S. and Soviet biomedical researchers have been investigating the effects of space
flight and microgravity on human immune function since the inception of manned
space flight. However, the programs have been modest and the findings inconclusive.
Although Skylab crews showed increased rates of gingivitis, postflight
phytohemagglutinin (PHA) stimulation of lymphocytes taken from Skylab astronauts
remained within preflight ranges (i.e. were not depressed). Postflight ribonucleic acid
synthesis was reported to be decreased concomitant with an decrease in absolute
leukocyte count.
The Soviets reported decreased tritiated uridine uptake in the lymphocytes of
cosmonauts following the flights of Soyuz 6, 7, 8, and 9. Numerical measurements of
lymphocytes and other leukocytes reported in these and other Soviet studies imply a
transient postflight leukocytosis and lymphocytopenia. However the general theory
that lymphocyte blast transformation is reduced in response to space flights was not
supported by data from the flights of Soyuz 24, Salyut 5, Soyuz 26, Soyuz 27, or the
Soyuz 28/Salyut 6 (98-day) mission. The Soviets reported increases in spontaneous
lymphocyte activity and PHA-induced blastogenesis after these missions. Following
the 140-day mission to Salyut 6, the Soviets again reported decreases in T
lymphocyte number and impaired blast transformation.
Thus, at the beginning of the Space Shuttle Program, there were data suggesting that
the in-vitro stimulability of lymphocytes was transiently depressed postflight, but much
of the data were invalid or contradictory. Using an improved technique, it was later
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demonstrated that the in-vitro blastogenic responsiveness of space crew peripheral
blood lymphocytes was reduced by as much as 92 percent following short-duration
Space Shuttle missions. Furthermore, data obtained from samples collected before
and after 11 of the first 12 U.S. Space Shuttle flights generally show that absolute
lymphocyte numbers, mitogen-induced blastogenesis, and circulating eosinophils are
all transiently reduced after flight. Since these results are similar to functional changes
exhibited by leukocytes from humans exposed to physical/emotional stress, a direct
causal relationship to microgravity or other space-flight-unique stressors could not be
established. Using monoclonal antibodies to surface antigens, flow cytometric
analysis of lymphocytes taken from 11 crewmembers from STS-41B and STS-41D
demonstrated a postflight decrease in circulating B lymphocytes and monocytes.
Reduced PHA transformation correlated with the demonstrated lymphocytopenia and
monocytopenia. Since monocytes are important accessories to T cell activation,
through the action of cytokines, these findings suggest a mechanism for the postflight
hyporeactivity of T cells to PHA.
In the area of cytokine/lymphokine research, interferon alpha/beta production has
been studied in vitro using lymphocytes taken from four cosmonauts sampled pre- and
postflight. However, the data were inconclusive.
In-vitro tests, stimulation of non-crewmember donor cells flown in space produced five
times the levels of interferon alpha/beta as stimulation of ground controls. In the U.S.,
the antiorthostatic, hypodynamic, hypokinetic suspension of rodents in a 15-20 degree
head-down posture (a model often used to simulate space-flight-induced changes in
bone and muscle) resulted in an 80-percent suppression of interferon alpha/beta
production. Decreased interferon production was also shown to correlate with
enhanced susceptibility of rats to Encephalomyocarditis (EMC) virus. On Shuttle
Spacelab-3 (SL-3), 9 of 10 test rats showed no measurable interferon production.
Because of the importance of the roles that the interferons, interleukins, and other
immunoregulatory molecules play in the immune response, future studies will
elucidate the relationship between space flight and lymphokine/cytokine production.
The immunological studies flown on Cosmos biosatellites 1884 and 2044 were
designed to test the efficacy of tail suspension as a model for microgravity-induced
changes in immune function, the ability of bone marrow cells to respond to
granulocyte/monocyte colony stimulating factor (GM-CSF) and the distribution of
immunologically active cells after space flight as compared with 1-g controls. Results
indicate that bone marrow cells from both flight and suspended rats had reduced
capacities to respond to GM-CSF compared to cells from controls. A higher
percentage of spleen cells from flown rats expressed T-helper and cytotoxic-
suppressor T-cell markers than did those from controls; and, in the bone marrow,
higher percentage of T-helper, suppressor-cytotoxic T, anti-asialo-GM-l-positive and
IL-2 receptor-bearing lymphocytes were found in rats after space flight. Cells from tail-
suspended rats, however, did not show these same increases. Therefore, tail
suspension in 1-g does not induce the complete pattern of immunological changes
associated with space flight.
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7.3 CRITICAL QUESTIONS (In priority order)
. Does space flight affect the humoral or cell-mediated immune functions,
nonspecific immunity, or immune surveillance capabilities of space crews
in a manner that would expose them to unacceptable medical risk while
on a mission, upon return to Earth, or as a consequence of repeated
mission exposure?
. What are the time course and magnitude of space-flight-induced
changes in the surface phenotypes (subpopulations), circulation
patterns, or functional capacities of the cells of the immune system,
including mucosal, humoral, cell-mediated and immune surveillance
systems?
a° What factors cause or otherwise influence the consistently
demonstrated post-flight reduction in blastogenic responsiveness
to nonspecific mitogens (PHA, Con A, LPS)?
b° What are the dynamics of the leukocyte count during space
flight with respect to:
• induction of of neutrophilia, lymphopenia, monocytopenia
or eosinopenia
• numbers and functional capacity of natural killer (NK) cells
• other changes in the WBC differential count, or the
circulation/sequestration of immunologically active cells?
. Are there in-vitro tests that reliably predict decreases in immune function
in space flight?
. What is the prevalence and severity of infectious disease and
carcinogenesis in crewmembers within 90 days of return from a
mission m 1 year, 2 years, etc. (longitudinal study)? Does this
prevalence suggest that space flight was a predisposing factor in
disease incidence, severity, or delayed rate of recovery?
a. Does the length of flight or other mission characteristic affect the
postflight recovery rate or acceptability of medical risk based on
demonstrated changes in immune competency?
° What are the relationships between the stressors associated with space
flight; the source, duration and magnitude of the stressor; and decreased
immune function?
a° Are there effective operational procedures or countermeasures to
counteract the stressors or their effects?
° Are there terrestrial (1 g) human, animal and/or computer models that
simulate or reproduce the effects of space flight/microgravity with
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sufficient validity that experimental results are reliable and predictive of
immune responses in space?
. What are the effects of space flight on the functional capacities of the
effector/accessory cells of specific or nonspecific immunity (monocytes,
neutrophils, macrophages, lymphocytes, and NK cells)?
. Do any of the changes in the immune system predispose crewmembers
either during or after flight to infectious diseases, allergies, or delays in
recovery from disease or wound healing?
. How long do neutrophilia, lymphocytopenia, monocytopenia,
eosinopenia, and reduced blastogenic responses persist after flight?
10. Are there other in-vitro/biochemical assays that reliably predict or reflect
decreases in immune function and if added to the current battery of
postflight tests, would give a more complete picture of factors affecting
immune function?
8.0 METABOLISM AND NUTRITION
8.1 INTRODUCTION
The metabolic status and nutritional requirements of human beings are known to be
affected by changes in physiological states. The major biologic effects associated with
the weightless environment of space flight include bone demineralization,
cardiovascular deconditioning, muscle atrophy, body fluid changes, and
neurophysiological dysfunctions. These physiological responses to weightlessness,
as well as the limited food choices, and exposure to radiation during space flight, can
all potentially affect human metabolism and nutritional requirements, which in turn
affect physiological systems. Thus, metabolic regulation and nutritional balance are
integral parts of maintaining astronauts' health and performance in space.
During acute and long-term exposure to microgravity, the metabolic needs and energy
requirements of individuals may change relative to their requirements on the ground.
Therefore, human metabolic efficiency and steady-state energy expenditure in space
during nominal activities, exercise, and extravehicular activities should be determined.
If there are changes, key physiological factors underlying the differences must be
elucidated.
The physiologic changes for which countermeasures are being considered include
bone demineralization, muscle atrophy, body fluid shifts, and electrolyte imbalances.
All of these changes can be affected by an individual's metabolic and nutritional
status; therefore, nutritional countermeasures are believed to be an integral part of
other countermeasure programs. In-flight exercise, for example, is considered a
primary countermeasure against muscle atrophy, and, with appropriate weight
loading, may also be useful in minimizing bone demineralization. Provision of
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adequate protein or special amino-acid combinations may aid in preventing muscle
atrophy.
The therapeutic effect of any drug is dependent upon the rate at which it is absorbed,
metabolized, and eliminated, as well as its volume of distribution within the body.
Changes in gastrointestinal, hepatic, or renal function or in circulatory dynamics may
modify the pharmacodynamics of a number of drugs and the function of the
gastrointestinal tract, liver, and kidneys during space flight should be established.
8.2 BACKGROUND AND CURRENT KNOWLEDGE
With the exception of energy, no nutritional requirements have been evaluated as yet
for living in space. The nutrients provided to meet the metabolic needs of astronauts
have been considered adequate for space flights of short duration. However, with the
90-day tours projected for the Space Station Freedom, nutritional and metabolic
studies are essential. Energy deficits and body weight losses that were sustained on
short missions may not be tolerated on missions of long duration.
During the early space missions, it was assumed that fewer calories would be required
in space than on Earth because of the reduced muscular load in a weightless
environment. This assumption has been proven incorrect. Experience gained from
longer flights, during which loss of body weight was significant, led to increasing the
total energy content of the space diet from 2500 kcal/day to about 3000 kcal/day. In an
effort to meet energy demands for sustained performance, the proportions of protein,
fat, and carbohydrate were adjusted to provide more protein and carbohydrate and
less fat. In-flight weight losses have not been abolished. The physical condition of
astronauts seems to improve when increased caloric intake was accompanied by an
elevated level of exercise. On the longer Soviet space flights, the total energy content
of the diet and both the intensity and variety of the exercise program have been
progressively increased.
In addition, on early space missions, dietary palatability was low, and the intended
quantities were not always consumed. However, in the Shuttle program, the variety of
foods and dispensing techniques has been increased and palatability improved.
Because storage has been a problem in terms of weight and bulk, dehydrated and
thermostabilized foods that could be reconstituted aboard the spacecraft have been
preferred by NASA. In an effort to provide a diet meeting the necessary requirements
for calories, electrolytes, and nutrients compatible with metabolic balance, a
standardized menu that accommodated individual food preferences was designed.
In order to provide protocols for Space Station Freedom, the methodologies
associated with nutritional and metabolic requirements for long-duration flight should
be tested on Shuttle missions, and operational data should be obtained for evaluation
and possible extrapolation to long-term flights.
Soviet scientists have observed changes in some biochemical indices of GI function in
rats exposed to microgravity, in subjects undergoing experimental bedrest, and in
cosmonauts after space missions. Alterations in GI function will become more
important with longer missions, since the GI tract directly influences absorption of
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nutrients and fluids as well as orally administered drugs. GI function is currently being
evaluated in bedrest subjects using techniques to estimate rates of gastric emptying
and GI motility• Pilot studies suggest that GI function is indeed altered during bedrest.
Further, the phamacokinetics of scopolamine were studied in subjects undergoing
antiorthostatic (6 degrees head-down) bedrest after intravenous or oral administration,
and its bioavailability was found to decrease significantly during the bedrest period•
The pharmacokinetics of orally administered acetominophen and
scopolamine/dextroamphetamine was evaluated during brief Shuttle flights, and
preliminary pre- to in-flight comparisons indicate changes in drug-concentration
profiles. Therefore, alternatives to oral administration (i.e. parenteral routes) may be
more appropriate for treating disorders, such as space motion sickness, that have a GI
component• During flight, differences during the absorption phase are more
pronounced than those during the elimination phase• These limited in-flight data are
inadequate to characterize the degree, magnitude, or mechanisms underlying space-
flight-induced pharmacokinetic changes• They do, however, suggest that drug efficacy
may differ in space, and allow identification of some of the variables that may influence
disposition profiles. This information can also be applied to identifying and
characterizing alterations in key processes within the body that are relevant to overall
metabolic homeostasis in humans•
Increase in glycogen deposition has been noted after flight in rodents' muscle and
liver, indicating that the control of intermediary metabolism is modified during space
flight.
Research efforts can be grouped roughly into: quantifying energy requirements in
space; evaluating methods of body-composition analysis; quantifying nutrient and
micronutrient content of astronauts' diet; examining drug pharmacodynamics (both
generally and for specific drugs); and developing countermeasures. It should be
noted that, historically, data concerning nutrition and human metabolism, whether
before, during, or after flight, have been difficult to obtain; careful advanced planning
for obtaining such data from crews who remain in space for 3 months will be required.
8•3 CRITICAL QUESTIONS (In priority order)
• Does space flight alter the energy requirements of humans, in particular,
the minimum and nominal energy requirements? How do these
requirements change during long-term acclimatization to space flight? Is
the basal metabolic rate and metabolic efficiency altered during
extended space flight? Are there changes in energy metabolism and
storage in space, especially in substrate utilization?
• What are crew food consumption patterns during space flight? What are
the effect of changes in cell and nutrient turnover during space flight on
nutritional requirements? What are the optimal noninvasive
microanalytical methods and techniques for use during space flight to
monitor nutritional status?
o What are the mechanisms underlying the negative nitrogen balance and
changes in lean body mass incurred during space flight? What are
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possible interventions, including dietary alterations in proteins and amino
acids?
. What are the pharmacokinetics (absorption, distribution, metabolism, and
elimination) of drugs likely to be used in space? Which methods of
administering drugs are the most effective in providing a predictable
response during space flight?
o Do the effects of space flight require added supplements of vitamins,
minerals, or other nutrients? What is the safe range of exogenous
vitamin intake for long-term space flight? Are nutritional requirements
modified by transient digestive disturbances, such as the anorexia,
nausea, and vomiting associated with space sickness?
o What are the energy requirements of EVA? What are the effects of
deconditioning, EVA, and countermeasures on nutritional requirements
and body composition during space flight?
o Are there valid ground models and analogs for the study of the effects of
space flight on nutrition?
° What is the time course and nature of body composition change due to
space flight? Do changes in body composition (age and gender) have
an effect on crew health and performance?
o What is the optimal presentation, nutritional and caloric formulation of the
diet for maintaining crew health and performance in space flight? What
are the behavioral and performance responses of individuals to
particular food constituents during space flight? Are there changes in
dietary preference?
10. Is there a change with respect to "food allergies" or other abnormal
reactions to foodstuffs? Is there an accumulation of heavy metals and/or
other toxic metals or compounds during long-term bedrest or space
flight?
11. Does space flight alter gastrointestinal physiology, including the
absorption of essential nutrients and the functioning of gut flora? What
are the effects of space flight on liver function? Are the effects
progressive? Are they reversible?
12. What are the effects of space-flight-related factors, (e.g. bone
demineralization and light spectrum) on nutritional requirements?
13. What changes in carbohydrate/lipid metabolism occur during
space flight? Are they modified by dietary intake?
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9.0 TEMPERATURE REGULATION
9.1 INTRODUCTION
Temperature regulation in mammals is an example of a highly complex regulatory
system maintaining homeostatic conditions in the face of wide variation in
environmental conditions. Temperature regulation in mammals has been extensively
studied from pharmacological, physiological, psychological, neurobiological, and
anatomical standpoints. Thermoregulation involves a continuum of neural structures
including the limbic system, lower brainstem, reticular formation, spinal cord,
sympathetic ganglia, and the hypothalamus. Gordon and Heath (see 6.0, Selected
References) have summarized the current view on effectors controlled by this
continuum. Other than sweat glands and brown adipose tissue, no specific organs
have been identified as being used primarily by the thermoregulatory system. Rather,
temperature regulation has evolved through the utilization of pre-existing physiological
systems, e.g. the locomotor system for shivering, cardiovascular system for
temperature control, and respiratory system for evaporative heat loss. Many neural
studies on the control of effectors are motivated by an interest in the complexity of the
system and an interest in describing neural activity, particularly in the hypothalamus, a
key site for the integration of sensory signals to provide appropriate efferent controlling
signals.
In man, except for an occasional episode of fever or exercise-induced hyperthermia,
body temperature rarely varies more than 2 degrees C about baseline throughout an
individual's lifetime. A normally functioning thermoregulatory system is vital for the
health of the individual. For example, thermoregulation is drastically impaired by the
alterations in body fluids that can occur during dehydration. Sustained high fever can
be damaging. Moreover, numerous epidemiological studies have documented the
adverse effects of low ambient temperatures on elderly individuals. Even transient
exposure to high temperatures leads to discomfort and radically impairs sleep and
performance.
Alterations in core temperatures have been observed during space flight and have
attracted attention to the thermoregulatory system as a system that is modified by
exposure to a microgravity environment. These observations on COSMOS and
Spacelab flights have led to numerous NASA-supported studies on this regulatory
system in a hypergravic environment, so that at this time a description of
thermoregulation as a function of gravity is beginning to emerge. Further information
is needed to more completely detail thermoregulatory mechanisms, especially in a
partial-g or microgravity environment, as this system is important for optimal function of
humans in space.
Examples of NASA analyses with regard to temperature regulation are those in the
1988 report entitled, NASA Workshoo on Biological Adaotation. This report briefly
reviews studies in hypergravic and microgravity environments, and concludes by
stating that remaining basic areas that merit further investigation include determining
in more detail how gravity influences temperature regulation.
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With further information on the interaction of ambient temperature and the effects of
altered gravitational fields (e.g. fluid shifts) on comfort and performance of humans in
space, more exact engineering specifications for spacecraft design can be
established.
9.2 BACKGROUND AND CURRENT KNOWLEDGE
While there have been relatively few experiments conducted in space on temperature
regulation in mammals, there is convincing evidence that temperature regulation is
altered in space flight. During the flight of COSMOS 1514, body temperature of a
monkey was monitored via biotelemetry implants. Microgravity appeared to alter the
steady-state regulation of body temperature, since over the course of the 5-day flight
there was a reduction in core temperature. The circadian rhythm was maintained but
the phase and/or period were altered. Similar observations were made in rats flown
on Spacelab 3. Such alterations were not observed in heart rate or activity. These
observations support the hypothesis that at least two neural oscillators are involved in
the generation of circadian rhythms and, furthermore, suggest that the temperature
oscillator is gravity sensitive. Informal discussions with Soviet scientists have revealed
that cosmonauts are at times cold and require extra clothing, indicating modified
temperature regulation in space. All these observations are provocative, but further
experiments are needed to provide more detailed information on the nature of
thermoregulatory deficits in microgravity. It seems that the thermoregulatory system
functions optimally at 1 g and that core temperature is, at least initially, reset to a lower
level in microgravity.
Utilizing animal centrifuges, temperature regulation has been extensively studied in
hypergravic fields. Oyama and his colleagues in 1971 were the first to show that rats
exposed to a hypergravic field displayed a marked fall in core temperature, Tc. This
fall in Tc was followed by several hours of relatively constant, although low, body
temperature and then by a slow return toward normal levels over a period of several
days. This observation in rats has been verified by many studies in other laboratories,
and it formed the basis for more detailed investigations on altered neural control
leading to impaired activation of thermogenic effectors. The fall in Tc on exposure to
hypergravic fields has also been observed in dogs and monkeys. The numerous
studies of temperature regulation in hypergravic fields all point toward an impairment
of temperature regulation proportional to the intensity of the gravitational field. These
space-related research projects have further elucidated the nature of alterations
encountered in hypergravic fields.
9.3 CRITICAL QUESTIONS (In priority order )
. What are the effects of space flight on thermoregulation processes and
heat exchange?
. What are the compounded effects of microgravity and EVA on
thermoregulatory processes and heat exchange?
. What environmental conditions of space flight influence temperature
regulation?
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. What are the effects of prescribed countermeasures on
thermoregulation?
o How does the regulation of body temperature change during space
flight? How do these changes affect the response to thermal load?
So How are changes in body temperature or its regulation correlated with
metabolic rate and energy expenditure?
o How does space flight affect central and/or peripheral thermoregulatory
mechanisms?
10.0 TECHNOLOGY
The most critical requirements for in-flight research in regulatory physiology are
refrigerator freezers and blood and urine collection systems.
The development of an in-flight centrifuge for the generation of gravitational fields
other than microgravity in space flight would provide capabilities for 1-g fields for in-
flight controls and other 1-g studies; fractional g for threshold and planetary simulation
studies; hyper-g (1-2 g) for provocative testing; and artificial gravity studies. At a
minimum, this technology should be available for acute and chronic animal studies,
particularly using non-human primates. Human-rated facilities will be required if
artificial gravity fields are to be used as a countermeasure for crews in long-duration
stays in space.
Other technology requirements are driven by the need for ground-based and in-flight
techniques and sensors for measuring physiological information or sampling and
storing/analyzing biological specimens of interest. Sensors, and their mode of
attachment, must be of minimal impact on the subjects and capable of recording
accurate information for extended periods of time. Animal housing requirements will
necessitate the use of unrestrained animals in the future. In view of the fact that many
physiological and behavioral processes (e.g. almost all hormones, body temperature,
sleep, and performance) show pronounced fluctuations in time (both ultradian and
circadian in nature) over the course of the day, a complete understanding of how
microgravity affects these systems requires frequent in-flight sampling of the variable
in question. As such, advances in the state of implantable multichannel biotelemetry
systems and other noninvasive technologies will be required.
Biosample collections (e.g. blood, urine, feces, or biopsies) should also be made at
frequent intervals for accurate interpretation of the data. Techniques will be required
for taking frequent samples over extended periods of time. Moreover, collection and
analysis procedures should be microminiaturized both to protect the subject (human or
animal) and reduce the requirements for storage of material.
The continuous nature of the data collection in this discipline requires the ability to
collect and store large amounts of data. This is particularly true for sleep or other
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biopotential data. Thus, the development of intelligent data systems that are small
(can be worn by the crew or integrated into the animal habitats), capable of recording
from multiple channels, sampling at high frequencies, and have sufficient storage
capacity (possibly preprocessing the data to reduce this requirement) is required.
The planning for long-duration exploration missions requires an understanding in as
much detail as possible of the effects of prolonged exposure to microgravity on the
critical physiological systems of the body. All protocols for experiments in space that
propose to use single-point measurements for variables that show pronounced
ultradian and/or circadian variations should be examined to ensure that data, which
will be collected at enormous cost, are valid and meaningful. Therefore, efforts should
be made towards the standardization of techniques for the collection, processing, and
analysis of data/samples. Furthermore, any advances that can be applied to
advanced methodologies to simplify assay procedures in space will reduce
biospecimen sampling and storage requirements, reducing crew time and storage
space -- two majors impacts of life sciences on space research.
11.0 RESEARCH STRATEGY
11.1 APPENDIX
The Regulatory Physiology research area priorities for each of the NASA mission eras
are presented in Table 1.
RANKINGS OF
REGULATORY
PHYSIOLOGY
Table 1
RESEARCH AREA PRIORITIES
STS ERA
CURRENT
1992-1995
SPACE
STATION ERA
1991-2000
SPACE
EXPLORATION
ERA
2000-3000
RHYTHMS 1 1 2.5
ENDOCRINOLOGY 2 3 4.5
HEMATOLOGY 4.5 7 6
IMMUNOLOGY 4.5 3 2.5
METABOLISM/ 6 3 1
NUTRITION
FLUID & ELECTROLYTES 3 5 4.5
TEMPERATURE 7 6 7
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11.2 EXPERIMENTAL MODELS
11.2.1 Bioloaical Models
The combined use of human, animal, and organ/tissue/cell culture models for
experimentation will be essential for the understanding of the effects of space flight on
the regulatory physiology systems. While the major questions to be addressed are
often the same in animal and human studies, only human subjects will be appropriate
for certain studies, such as group social interactions, and psychological and
scheduling-related issues. Conversely, animal models will be required for other
studies that require precise control of the environment (particularly in space-flight
studies), variable gravity research (via centrifugation), and invasive preparations
considered inappropriate for humans. In addition, data obtained from animals will be
important for the design and interpretation of concurrent and follow-on studies in
humans.
Of particular note here is the use of nonhuman primate models for biomedical
research. Primates, such as the rhesus macaque or squirrel monkey, have been
repeatedly demonstrated morphological behavioral, and physiological similarities with
humans. This knowledge combined with the ability to study these animals using
invasive techniques in precisely controlled environments makes them powerful
models for the study of human biomedical problems. The utilization of these models in
long-term space studies will be a critical component of this Discipline Science Plan.
In addition to the space environment, space flight presents a number of special
stressors for the human crew. These include: (1) small group confinement for
extended periods, (2) a hazardous environment requiring ground-based support, and
(3) rigorous operational demands. While animal experiments can be expected to
provide insights and information about the response of mammals to space, many of
the issues raised above can only be addressed appropriately in humans.
11.2.2 Ground-Based Analogs
These studies should focus on the individual effects of the various environmental
changes associated with space flight. Human as well as various animal models will
be required for such a program. Minimally, this program should include the use of
both nonhuman primates and rodents. Of particular importance is the development of
experimental situations that can isolate the specific effects of changes in the
gravitational field on these various physiological systems.
The focus of ground-based studies should be on those issues that relate specifically to
future human voyages into space. The emphasis should be on the characterization of
the fundamental properties of these physiological systems in the space environment.
These include the effects of gravity and other space-related factors (e.g. radiation,
atmosphere, etc.) on the homeostatic and adaptive mechanisms of these systems.
The effects of gender and age on these parameters also should be considered.
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The types of analog models to be considered should include:
1. Centrifugation
• Hypergravity
• 1-g in-flight controls
• Fractional g
2. Antiorthostasis, hypodynamia, and hypokinesia
• Bedrest
• Suspension models
3. Closed operational environments
• Polar
• Submarine
• Hyperbaric
11.2.3 Mathematical Simulation
Mathematical models of physiological systems have been established in many of
these subdisciplines. The modeling approach is of interest to basic science because it
allows one to generate testable hypotheses, as well as testing the model itself.
Models also have considerable practical implications and modeling can lead to new
insight into the relevance of data obtained in animals to humans. Once established,
modeling can reduce the level of empirical testing necessary on biological subjects.
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